Ulrik Bangsbo Hansen

Partner
Ulrik Bangsbo Hansen
Location
Copenhagen
Language
English
Secretary
Services

Ulrik Bangsbo Hansen is Head of Life Sciences in DLA Piper Denmark. 

Ulrik is engaged in commercial and company law and has for many years been involved in advising on and drafting and negotiating commercial contracts. 

He is recognised by Chambers and a member of the Board of Danish Life Science Law Association (DALILA). 

Ulrik provides advice particularly within Life Sciences and coordinates DLA Piper Denmark’s cross-disciplinary advisory services. He has extensive sector knowledge and in-depth experience in regulatory issues and relevant specialist groups. His clients range from the world’s largest pharma and medical devices companies to start-ups and biotech companies.  

Furthermore, Ulrik acts for the energy sector, private equity funds and industrial investors on all legal aspects, including transactions, the drafting of contracts, negotiation, interpretation, dispute resolution as well as risk management. Ulrik also advises on distribution, facility management, technical outsourcing, PPP, service, operation, agencies, licences, franchising, OEM, ESCO, joint ventures, purchasing, development and technology.  

Moreover, he has a wealth of experience in investments as well as the sale and purchase of enterprises, where a large part of his advising concerns international issues. 

Ulrik regularly holds courses in Life Sciences, company law, M&A and contract law.  

He sits on several boards of directors, including of ARTSMedia Denmark ApS and Stroebech Media ApS. 

Qualifications
Education
Admitted to the Danish Bar
2000
Master of Law, University of Copenhagen
1997
Memberships

Legal Committee of Active Owners Denmark 

Experience
Recent highlights
  • Ulrik headed the legal team representing the major Danish pension funds ATP and PFA in connection with a substantial investment in DONG Energy/Ørsted. The legal services included negotiating the five-party agreement between the Danish State, DONG Energy, Goldman Sachs, ATP and PFA. The transaction won the International Financial Law Review award for the most innovative transaction in Europe.  
  • Ulrik assisted MedTech company Danaher in connection with its strategic acquisition of Lonza Copenhagen.  
  • Ulrik acted for AbbVie on its acquisition of Allergan and was in charge of the integration in Denmark. The global restructuring meant that two pharma companies were to be locally integrated. 
Career highlights

Partner, DLA Piper Denmark, since 2017 

Partner, LETT (DLA Piper Denmark), 2008-2017 

Attorney, LETT (DLA Piper Denmark), 2007-2008 

Attorney, Gorrissen Federspiel, 2000-2007 

Assistant Attorney, Gorrissen Federspiel, 1998-2000 

Positions of trust

Member of the Board, Danish Life Science Law Association (DALILA) 

Vice-Chairman of the Board of Directors, ARTSMedia Denmark ApS 

Chairman of the Board of Directors, Stroebech Media ApS 

Other positions

Former lecturer in the law of obligations at the University of Copenhagen. 

Rankings
Chambers

Clients value that Ulrik Bangsbo Hansen is "accommodating and easy to speak to. He's very skilled in M&A and is good at understanding the material issues in a transaction."